Liver Injury/Regeneration News

A higher proportion of patients hospitalized during the COVID-19 pandemic were alcohol-dependent, according to results presented at the International Liver Congress.

A novel liver dialysis device that rids the body of dysfunctional albumin and replaces it with fresh albumin significantly improved survival rates among patients with acute-on-chronic liver failure, according to a presenter at The International Liver Congress.

In preparation for the International Liver Conference June 23-26, Healio Gastroenterology and Hepatology presents the following report on the latest stories in liver research.

Patients with drug-indued liver injury had a long hospital stay, low morbidity and high mortality, according to a study published in the British Journal of Clinical Pharmacology.

The ACG developed recommendations for diagnosis and management of idiosyncratic drug-induced liver injury.

Bedside measures including activity, quality of life and physical function accurately predicted the risk for overt hepatic encephalopathy in patients with cirrhosis, according to results published in The American Journal of Gastroenterology.

The coagulopathy of COVID-19 driven by endothelial Factor VIII correlated with liver injury, according to a presenter at The Liver Meeting Digital Experience.

Children with COVID-19 and multisystem inflammatory syndrome had varied outcomes and liver injuries but all should keep long-term liver monitoring to ensure return to normal levels, per a researcher at The Liver Meeting Digital Experience.

Ursodeoxycholic acid treatment correlated with reduced mortality, need for liver transplantation and biliary tract cancer in patients with primary sclerosing cholangitis, according to a presenter at The Liver Meeting Digital Experience.

Randomized controlled trials are critical in finding an evidence-based treatment for patients with COVID-19, according to a presenter at The Liver Meeting Digital Experience.